Related Experiment Video
Updated: Oct 1, 2026

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Lobe-based Quantitative CT Assessment of Emphysema in a Retrospective Multi-center COPD Cohort: Correlations with
Guoqin Sun1, Pardis Bahadori1, He Hei1
1Department of Medical Imaging, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710061, P.R. China.
Objective:
This study aimed to investigate the correlation between lobe-based Low Attenuation Area percentage (LAA%) and spirometric parameters in patients with Chronic Obstructive Pulmonary Disease (COPD), and to evaluate LAA% distribution patterns across different stages of COPD as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification.
Methods:
A retrospective multi-center study was conducted involving 1,116 COPD patients who underwent non-contrast chest Computed Tomography (CT) and pulmonary function testing between December 2015 and December 2022. Patients were categorized into GOLD stages I-IV. CT images were analyzed using the FACT-Digital Lung™ software to quantify LAA% for each lobe and the whole lung. Group comparisons of LAA% and baseline characteristics were performed across GOLD stages. Correlations between LAA% and pulmonary function test parameters (FEV1% predicted and FEV1 /FVC) were assessed using Spearman's rank correlation test for unadjusted analyses and partial correlation (adjusting for age, sex, BMI, and smoking history) for adjusted analyses.
Results:
LAA% increased significantly as COPD progressed from GOLD II through GOLD IV across all lung lobes (P < 0.001), while no significant difference was found between GOLD I and II. The upper lobes consistently showed higher LAA% compared to lower lobes across all GOLD stages (P < 0.001). LAA% showed a significant inverse correlation with spirometric parameters. Stronger correlations were observed for FEV1 /FVC (r = -0.352 to -0.412) than for FEV1% predicted (r = -0.235 to -0.289), and all were significant (P < 0.001).
Discussion:
In this cross-sectional cohort, patients with early-stage COPD (GOLD I/II) showed significant functional impairment (reduced FEV1) without a corresponding significant increase in LAA% compared to GOLD I, whereas patients with moderate to severe COPD (GOLD III/IV) exhibited both functional impairment and elevated LAA%. This pattern is consistent with a dissociation between physiology and structure in early disease, and suggests that quantitative CT may be more sensitive to structural changes in advanced stages. However, due to the cross-sectional design, temporal relationships cannot be inferred.
Conclusion:
Lobe-based quantification of LAA% effectively reflects the severity and regional distribution of emphysema and demonstrates significant associations with airflow limitation. These findings provide additional structural insights into COPD heterogeneity and support the value of quantitative CT as a complementary tool for assessing structural lung changes in patients with moderate-to-severe disease. Given the crosssectional design, the observed associations do not imply causality; prospective studies are needed to elucidate the temporal sequence and underlying mechanisms.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...